v3 Template
E

Eloxx Pharmaceuticals, Inc.

Biotechnology / Pharmaceuticals ~280 employees
Founded
--
Employees (Est.)
~280
14 leaders known
Total Funding
$5.2M
Funding Rounds
2
Last Funding
2024-07-11

About Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals is a biotechnology company focused on leveraging innovative technology platforms to develop novel small molecule genetic therapies aimed at transforming genetic diseases by correcting nonsense mutations and ribosomal mutations.

Products & Services

CELX-02:A treatment for Alport Syndrome, a rare kidney disease.
Turbo-ZM™ RMAs:Ribosome Modulating Agents as part of their platform technology for genetic therapies.
Eukaryotic Ribosomal Selective Glycosides (ERSGs):A platform technology focused on transforming genetic diseases.
Pipeline for Nonsense Mutation Alport Syndrome:Therapies targeting Alport Syndrome caused by nonsense mutations.
Pipeline for Nonsense Mutation RDEB/JEB:Therapies for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and Junctional Epidermolysis Bullosa (JEB) caused by nonsense mutations.

Specialties

Small Molecule Genetic Therapies Nonsense Mutation Therapies Ribosomal Mutation Therapies Rare Kidney Diseases Genetic Disease Transformation

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt
T: -
FT: Debt
A: 3200000
MR: -
FA: $3.2 million
FAN: 3200000
D: 2024-07-11
FD: 2024-07-11
-
2 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 2000000
MR: -
FA: approximately $2 million
FAN: 2000000
D: 2023-09-19
FD: 2023-09-19
1 investors
Debt Latest
2024-07-11
$3.2M
Registered Direct Offering 2023-09-19
$2.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Sumit Aggarwal

President and Chief Executive Officer

D

Daniel Geffken

Interim Chief Financial Officer

T

Tomer Kariv

Chairman

L

Lindsay Androski

Director

S

Steven D. Rubin

Director

A

Alan Walts

Director

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

Eloxx Pharmaceuticals, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Pharmaceuticals
Company Size
~280 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro